TrialAntimicrobial agents and chemotherapy2023

Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE).

Jaime Altcheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.